Global Biosimilar Market Size to Reach USD 132.47 Billion in 2032 | Emergen Research
05 déc. 2023 09h23 HE
|
Emergen Research
Vancouver, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Global Biosimilar Market Poised for Rapid Growth with 17.9% CAGR, Fueled by Rising Cancer Cases and Regulatory Approvals In 2032, the global biosimilar...
Rituximab Biosimilars Global Market Report 2022: Major Players Collaboration in Development Driving Sector Forward
09 août 2022 05h28 HE
|
Research and Markets
Dublin, Aug. 09, 2022 (GLOBE NEWSWIRE) -- The "Rituximab Biosimilars Global Market Report 2022: By Application, By Distribution, By Route" report has been added to ResearchAndMarkets.com's offering....
Global Rituximab Biosimilars Market Opportunities and Strategies Report 2021-2030: Focus on Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Rheumatoid Arthritis
06 juil. 2021 05h18 HE
|
Research and Markets
Dublin, July 06, 2021 (GLOBE NEWSWIRE) -- The "Rituximab Biosimilars Global Market Opportunities and Strategies to 2030: COVID 19 Growth and Change" report has been added to ResearchAndMarkets.com's...
China Rituximab Market Report 2021-2025: A Monoclonal Antibody to Target Cells that have the CD20 Marker on their Surface
13 mai 2021 05h53 HE
|
Research and Markets
Dublin, May 13, 2021 (GLOBE NEWSWIRE) -- The "Investigation Report on China's Rituximab Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. According to this market...
Global Osteoporosis Disease Analysis Market Report 2020: Novartis has the Highest Number of Completed Clinical Trials for Osteoporosis with 120 Trials
01 févr. 2021 06h38 HE
|
Research and Markets
Dublin, Feb. 01, 2021 (GLOBE NEWSWIRE) -- The "Disease Analysis: Osteoporosis" report has been added to ResearchAndMarkets.com's offering. Osteoporosis is the most common metabolic bone disease, and...
Global Rituximab Biosimilars Market Report 2020-2030: COVID-19 Impacts, Growth and Change
07 janv. 2021 09h53 HE
|
Research and Markets
Dublin, Jan. 07, 2021 (GLOBE NEWSWIRE) -- The "Rituximab Biosimilars Global Market Report 2020-30: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering. Rituximab...
Rituximab Biosimilar Insight report on 35+ companies and 35+ marketed and pipeline drugs | DelveInsight
29 oct. 2020 18h00 HE
|
DelveInsight Business Research LLP
LA, USA, Oct. 29, 2020 (GLOBE NEWSWIRE) -- Rituximab Biosimilar Insight report on 35+ companies and 35+ marketed and pipeline drugs by DelveInsight “Rituximab– Biosimilar Insight, 2020” by...
MMR Information Systems Pursues International Patent Applications on Anti-CD20 Antibodies
22 juin 2009 08h44 HE
|
MMR Information Systems, Inc.
LOS ANGELES, CA--(Marketwire - June 22, 2009) - MMR Information Systems, Inc. (OTCBB: MMRF) (the "Company"), which through its wholly-owned operating subsidiary,
MyMedicalRecords, Inc. ("MMR")...